Treatment effects on neurometabolite levels in schizophrenia: A meta-analysis dataset of proton magnetic resonance spectroscopy.

Antipsychotic Gamma-aminobutyric acid Glutamate Glutamine MRS Myo-inositol N-acetylaspartate Psychosis

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 15 04 2020
revised: 15 05 2020
accepted: 08 06 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 9 7 2020
Statut: epublish

Résumé

This article describes a dataset for a meta-analysis that aimed to investigate the effects of treatment on the neurometabolite status in patients with schizophrenia (DOI of original article: https://doi.org/10.1016/j.schres.2020.03.069[1]). The data search was performed with MEDLINE, Embase, and PsycINFO. The neurometabolites investigated include glutamate, glutamine, glutamate + glutamine, gamma-aminobutyric acid,

Identifiants

DOI: 10.1016/j.dib.2020.105862 PMID: 32637482 PMC: PMC7327820
pubmed: 32637482
doi: 10.1016/j.dib.2020.105862
pii: S2352-3409(20)30756-3
pii: 105862
pmc: PMC7327820
doi:

Types de publication

Journal Article

Langues

eng

Pagination

105862

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships which have, or could be perceived to have influenced the work reported in this article.

Références

BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Schizophr Res. 2020 Jun 3;:
pubmed: 32505446
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518

Auteurs

Manabu Kubota (M)

Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Department of Psychiatry, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

Sho Moriguchi (S)

Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, 250 College Street, Toronto, Ontario M5T1R8, Canada.

Keisuke Takahata (K)

Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Department of Neuropsychiatry, Keio University Graduate School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Shinichiro Nakajima (S)

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, 250 College Street, Toronto, Ontario M5T1R8, Canada.
Department of Neuropsychiatry, Keio University Graduate School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Nobuyuki Horita (N)

Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

Classifications MeSH